Individualized vaccines for cancer
作者： Bernhard Renard , Cedrik Britten , Tana Omokoko , Michael Koslowski , Mustafa Diken
DOI:
关键词:
摘要: The present invention relates to the provision of vaccines which are specific for a patient's tumor and potentially useful immunotherapy primary as well metastases. In one aspect, method providing an individualized cancer vaccine comprising steps: (a) identifying somatic mutations in specimen patient provide mutation signature patient; (b) featuring obtained step (a). further obtainable by said method.
lens.org 参考文章(222)
Dirk Usener, Gerd Helftenbein, Michael Koslowski, Özlem Türeci, Volker Schlüter, Ugur Sahin, Identification of Surface-Associated Antigens for Tumor Diagnosis and Therapy ,(2006)
Philip Stephens, Sarah Edkins, Helen Davies, Chris Greenman, Charles Cox, Chris Hunter, Graham Bignell, Jon Teague, Raffaella Smith, Claire Stevens, Sarah O'Meara, Adrian Parker, Patrick Tarpey, Tim Avis, Andy Barthorpe, Lisa Brackenbury, Gemma Buck, Adam Butler, Jody Clements, Jennifer Cole, Ed Dicks, Ken Edwards, Simon Forbes, Matthew Gorton, Kristian Gray, Kelly Halliday, Rachel Harrison, Katy Hills, Jonathon Hinton, David Jones, Vivienne Kosmidou, Ross Laman, Richard Lugg, Andrew Menzies, Janet Perry, Robert Petty, Keiran Raine, Rebecca Shepherd, Alexandra Small, Helen Solomon, Yvonne Stephens, Calli Tofts, Jennifer Varian, Anthony Webb, Sofie West, Sara Widaa, Andrew Yates, Francis Brasseur, Colin S Cooper, Adrienne M Flanagan, Anthony Green, Maggie Knowles, Suet Y Leung, Leendert HJ Looijenga, Bruce Malkowicz, Marco A Pierotti, Bin Teh, Siu T Yuen, Andrew G Nicholson, Sunil Lakhani, Douglas F Easton, Barbara L Weber, Michael R Stratton, P Andrew Futreal, Richard Wooster, None, A screen of the complete protein kinase gene family identifies diverse patterns of somatic mutations in human breast cancer Nature Genetics. ,vol. 37, pp. 590- 592 ,(2005) , 10.1038/NG1571
Mohan Srinivasan, Alan J. Korman, Josephine M. Cardarelli, Bingliana Chen, Changyu Wang, Mark J. Selby, Human monoclonal antibodies to programmed death 1(PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics ,(2006)
Ingmar Dr. Hoerr, Florian Von Der MüLBE, Steve Dr. Pascolo, Immunostimulation by chemically modified RNA ,(2003)
Giorgio Parmiani, Annamaria De Filippo, Luisa Novellino, Chiara Castelli, Unique human tumor antigens : Immunobiology and use in clinical trials Journal of Immunology. ,vol. 178, pp. 1975- 1979 ,(2007) , 10.4049/JIMMUNOL.178.4.1975
Kenechi Ejebe, Gregory J. Sieczkiewicz, Jason P. Schrum, Sayda M. Elbashir, Engineered nucleic acids and methods of use thereof ,(2011)
Rodrigo Goya, Mark G.F. Sun, Ryan D. Morin, Gillian Leung, Gavin Ha, Kimberley C. Wiegand, Janine Senz, Anamaria Crisan, Marco A. Marra, Martin Hirst, David Huntsman, Kevin P. Murphy, Sam Aparicio, Sohrab P. Shah, SNVMix: predicting single nucleotide variants from next-generation sequencing of tumors Bioinformatics. ,vol. 26, pp. 730- 736 ,(2010) , 10.1093/BIOINFORMATICS/BTQ040
Hüseyin Firat, Francois A. Lemonnier, Michelle Down, Joy Gardner, Qiyuan Chen, Suzanne L. Elliott, Stephanie J. Pye, Andreas Suhrbier, Christopher Schmidt, Luis Mateo, Jonathon Cebon, An HLA-A2 polyepitope vaccine for melanoma immunotherapy. Journal of Immunology. ,vol. 163, pp. 4058- 4063 ,(1999)
Martin Smithkline Beecham Biologicals S.A. Friede, Nathalie Marie-Josephe Claude Garcon, Vaccines containing a saponin and a sterol ,(1996)
Ali Gure, Lloyd J Old, Jan W Drijfhout, Matthew Scanlan, Alexander Knuth, Yao-Tseng Chen, Elke Jager, Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof ,(1997)